VERIFY RECORD
Suki AI
4 of 10 claims verified
4 of 10 key claims verified, 5 plausible, 1 thin (self-reported revenue growth); no lawsuits or contradictions found
Claims
- [verified]
Suki was founded in 2017 by Punit Soni (former Google advisor, Motorola Mobility VP of Product, and Flipkart Chief Product Officer) to build an AI voice assistant that reduces clinician documentation burden.
Founding year and founder background corroborated across three independent sources.
- [verified]
Suki has raised a total of $168 million in venture funding, including a $70 million Series D in October 2024 led by Hedosophia.
Healthcare Dive (independent trade press) confirms $70M raised and $165M cumulative as of October 2024; Suki's own January 2025 release updates the cumulative total to $168M after a follow-on Zoom Ventures investment.
- [plausible]
The October 2024 Series D valued Suki at approximately $500 million.
Figure comes from data aggregators citing unnamed sources familiar with the deal. Suki has not disclosed a valuation in its own press materials, and no directly fetched news article stated the number in its own text.
- [verified]
More than 300 health systems and clinics use Suki's ambient AI assistant (300+ in December 2024, growing to 350+ by January 2025).
Independent trade press (MedCity News) and Suki's own release cite consistent, growing figures a month apart.
- [plausible]
athenahealth named Suki its Preferred Solution Partner for ambient intelligence on January 26, 2026, citing 450+ practices and 3,400 monthly active users across Suki for Clinicians and Ambient Notes, 50 percent growth in six months, about 500,000 notes generated monthly, and reach into athenahealth's network of 170,000 providers.
Widely syndicated (BusinessWire, Morningstar, Yahoo Finance) but all copies trace to one Suki-issued release; figures are self-reported and not independently audited.
- [plausible]
A 2024 KLAS Emerging Company Spotlight Report gave Suki Assistant a 93.2 overall performance score based on 15 surveyed organizations, with 95 percent saying they would buy again, clinicians completing notes 72 percent faster on average, and 9x ROI in year one.
KLAS Research is an independent healthcare IT research firm, and its own site confirms the report's existence, date (April 17, 2024), and scope. The specific score and percentages, however, are sourced from Suki's press release republishing the findings; the underlying KLAS report text is paywalled.
- [thin]
CEO Punit Soni stated Suki doubled its revenue in 2023 and was on track to quadruple revenue in 2024.
Single self-reported CEO statement with no audited revenue figures disclosed anywhere. The source page returned a bot-wall error (403) on direct fetch, so this rests on the article's headline and search-indexed snippet rather than confirmed full text.
- [plausible]
Suki's headcount is roughly 390 to 413 employees as of mid-2026.
Third-party data-aggregator estimate (Tracxn, cross-checked against PitchBook and other listings in the same range); Suki does not publish headcount itself.
- [verified]
Suki expanded its Google Cloud partnership in December 2024 to add patient-summary and clinical Q&A features built on Vertex AI, which CEO Punit Soni said no other AI healthcare assistant offered at the time.
Independently reported by MedCity News. The CEO's claim of being first-to-market is itself unverified marketing language, not an independently confirmed fact.
- [plausible]
Zoom Ventures and Salesforce CEO Marc Benioff are investors in Suki.
Zoom Ventures' investment (announced January 30, 2025) is confirmed directly by Suki's own release, though the dollar amount was not disclosed. Marc Benioff's angel stake appears only in third-party aggregator listings (Tracxn), not in any fetched primary announcement.
Gaps
- No lawsuits, regulatory actions, or privacy complaints against Suki were found in this research pass, unlike several peer ambient-scribe vendors.
- Exact dollar amount of the Zoom Ventures investment was not disclosed by either party.
- No audited financial statements or independently verified ARR figure could be found; all revenue figures are self-reported by the CEO in press coverage.
- Could not confirm whether the $500 million valuation was ever officially acknowledged by Suki itself.

